We have partnered with international experts to provide rare bone diseases highlights from ASBMR 2021.
This is the second in a series of four podcasts. In this episode Dr Oliver Semler has selected and discusses his highlights.
Do you know how to differentiate between growth hormone deficiency (or GHD) and primary IGF-I deficiency (or growth hormone resistance) and the key challenges...
Gene therapy and gene-modified cell therapies have a great potential for rare diseases to either help patients to cure their disease or improve their...
Robert Mitchell-Thain, CEO of the PBC Foundation, Edinburgh, UK and Kath Houghton, Autoimmune Specialist Nurse, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK,...